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Introduction
Dehydroamino acids such as dehydroalanine (Dha, 1) and dehydrobutyrines (Dhb, 2a and 2b) are naturally occurring amino acids that are present in a range of peptides 1 including antimicrobial peptides of the lantibiotic family. 2 In lantibiotics such as nisin A, dehydroalanine (1) and dehydrobutyrine (2a and 2b) react via Michael addition with cysteine residues to form lanthionine and methyl lanthionine thio-ether bridges, respectively. 2d In nature the site-specific introduction of (1) and (2) into peptide chains arises due to enzymatic post-translational modifications, in which either serine or threonine residues are dehydrated by phosphorylation followed by b-elimination.
3 Recently, dehydroamino acids have also served to provide synthetic handles, enabling a highly useful route for tagging both short peptides and proteins. 4 The formation of dehydrolanine (1) can be readily achieved from cysteine both as the free amino acid 5 and within larger protein structures via a variety of reaction conditions. 4b, 6 The synthesis of both dehydrobutyrine isomers (2a and 2b) is possible from threonine using a range of reaction conditions. 7 Often the formation of 2a or 2b from threonine requires harsh reaction conditions, and generally involves electron-withdrawing substituents, e.g., Boc or nosyl, at the amino group of the amino acid to increase the acidity of the a-H. 8 Dehydrobutyrines can also be stereospecifically prepared by oxidative elimination of phenyl-selenocysteines. However, this requires several synthetic transformations from commercially available threonine prior to the elimination step 9 ( Fig. 1 ).
Herein, we report a mild one-pot method for the synthesis of a novel dehydrobutyrine-containing amino acid.
Results and discussion
Recently we have shown that pentafluoropyridine (3) reacts with orthogonally protected serine derivatives (e.g., 4 and 5) as a route to generating novel peptide building blocks (6 and 7) (Scheme 1). 10 As part of this work, it was observed that under certain reaction conditions, typically an excess of base, dehydroalanine derivatives (8 and 9) were also formed as by-products.
The formation of 8 and 9 arises due to abstraction of the acidic a-H and elimination of the stable 4-(tetrafluoropyridine)-oxide leaving group (10) . In an effort to expand and exploit this observation to access a range of novel dehydrobutyrines potentially 
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Tetrahedron j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / t e t useful in peptide chemistry, we investigated the reaction between pentafluoropyridine (3) and various threonine derivatives (Scheme 2).
The treatment of BoceThreOMe (11) with 3 (2 molar equiv) in the presence of K 2 CO 3 (3 molar equiv) at room temperature did not yield any elimination products (Scheme 3).
It was envisaged that the introduction of a more electronwithdrawing group on the amine, e.g., 4-tetrafluoropyridyl rather than Boc, would make the a-hydrogen more acidic and thereby promote the desired elimination. As such, under the above conditions, the reaction between mono-protected threonine methyl ester 12 and pentafluoropyridine (3) afforded the single elimination product 4-(N-tetrafluoropyridine)-Dhb-OMe (13) exclusively and salt 10 (Scheme 4a).
1 H NMR analysis of the crude reaction mixture showed no signals in the a-H region (d 4.00e6.00) and a quartet at d 6.76e6.85 (J¼7.2 Hz), which was consistent with the formation of a derivative of 2. 7 Purification involved an initial filtration step to remove K 2 CO 3 from the mixture, after which the dehydrobutyrine 13, which was found to be stable on silica, could be easily separated from the leaving group anion 10 by column chromatography. Initially, 13 was obtained as a white crystalline solid in a modest 25% yield. In an attempt to account for the lower than expected recovered mass, the filtration step was replaced with partitioning between CHCl 3 and water, affording pure product 13. By modification of the work up conditions the isolated yield was considerably improved to 65% and avoided the necessity for column chromatography. Replacement of K 2 CO 3 with N,N-diisopropylethylamine (DIPEA), afforded two products, which were distinguishable by 1 H and 19 F NMR analysis of the crude reaction mixture (Scheme 4b). Following isolation, the products were identified as N-substituted tetrafluoropyridine-L-threonine methyl ester (14, 28%) and dehydrobutyrine 13. It therefore appeared that under these conditions the reaction failed to reach completion and that compound 14, Scheme 1. Elimination to afford dehydroalanines as a by-product.
Scheme 4. Reaction of L-threonine methyl ester (12) with pentafluoropyridine (3).
Scheme 2. General scheme for conversion of threonine derivatives in to dehydrobutyrines.
Scheme 3. Reaction of BoceThreOMe (11) with pentafluoropyridine (3).
arising by substitution on the nitrogen of the threonine prior to the substitution on the b-hydroxyl group, is an intermediate required for the transformation into dehydrobutyrine 13. It was considered that this may be present due to loss of volatile pyridine 3 during the reaction. Returning to using potassium carbonate as the base, but this time adding a total of 6 equiv of pyridine 3 in aliquots of 2 equiv/day over 3 days did not improve the conversion to product 13. However, under these reaction conditions the putative intermediate 15 was formed. This prompted the suggestion that the elimination mechanism proceeded via disubstituted threonine methyl ester intermediate 15; the structure of which was confirmed by X-ray crystallography (Fig. 2) . Moreover, the X-ray structure of intermediate 15 clearly shows that in the crystal form at least, the a-H and the leaving group have the requisite antiperiplanar relationship needed to undergo elimination.
The mechanism of the formation of dehydrobutyrine 13 is, therefore, hypothesised to proceed by sequential substitution reactions of pentafluoropyridines; by reaction of first the nitrogen nucleophile to give intermediate 14 and then the b-oxygen nucleophile, affording intermediate 15 followed by elimination (Scheme 5). Whilst the first addition probably occurs rapidly, the second seems to follow rather more slowly, given the isolation of intermediate 15, reflecting the lower nucleophilicity of O compared to N and steric effects. The elimination step would be expected to ensue relatively quickly once the leaving group has been installed, due to ready deprotonation of the acidic a-hydrogen present in intermediate 15.
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In order to determine, which geometric isomer (13) was obtained from the elimination reaction a 1 H NOESY NMR experiment was performed. This showed a correlation between the amino group NH and the b-CH 3 , whilst no coupling was visible with the b-H, indicating that only the Z-isomer was formed. Confirmation of the predicted stereochemistry of dehydrobutyrine 13 was further provided by single crystal X-ray crystallography, which clearly shows the Z-configuration of the alkene (Fig. 3) . The mechanism for the formation of the alkene products was initially predicted to proceed via a concerted E2 elimination of the alkoxide from the doubly substituted fluoropyridine adduct 15. This is reported to be the process by which dehydroalanines may be prepared synthetically. 7 However, the additional a-C anion stabilising effects of flanking electron-withdrawing groups in intermediate 15, i.e., a methyl ester and a 4-tetrafluoropyridylamine group, not only increases the rate of elimination but may also serve to favour a possible E1cb mechanism. E1 elimination was considered to be improbable due to the required formation of a relatively unstable 2 carbocation at the b-position.
In order to define the exact mechanism by which elimination takes place, an experiment involving L-allo-threonine methyl ester (16) was carried out. Fig. 4 shows that in the case of the E2 mechanism, the geometry of the resulting alkene is influenced by the configuration of the starting threonine derivative. Enantiomers, e.g., L-ThreOMe and D-allo-ThreOMe are expected to give rise to the same alkene, whereas diastereomers, e.g., L-allo-ThreOMe and D-ThreOMe should afford the opposite alkene geometry when the required antiperiplanar arrangement is adopted with respect to leaving group and the a-H. The result of a concerted E2 elimination from the N,O-disubstituted adduct would be predicted in the case of L-allo-ThreOMe to afford the E-alkene as shown by the Newman projections in Fig. 4 .
An elimination reaction was therefore performed on L-alloThreOMe (16) using the same reaction conditions that converted the diastereomer, L-ThreOMe (12) , in to the Z-isomer (13). Three compounds were isolated from the product mixture: a dehydrobuytrine, the N-substituted adduct (17) and the N,O-disubstituted adduct (18) (Scheme 6). Surprisingly, the only dehydrobutyrine product obtained was confirmed to be the Z-isomer of dehydrobutyrine 13 by 1 H NOESY NMR analysis and X-ray crystallography. This result ruled out the anticipated E2 elimination mechanism, which would have generated the E-isomer of dehydrobutyrine 13.
The findings from the elimination reaction involving compound 16 are, however, consistent with the E1cb mechanism shown in Scheme 7. Removal of the acidic a-H would afford a relatively stabilised carbanion, leading to a mixture of products arising from the anti-elimination from diastereomers L-allo-Thr and D-allo-Thr if an E2 elimination mechanism predominated (Fig. 4) . Alternatively, the observed outcome may be explained by resonance stabilisation by the carbonyl group (well documented for E1cb), which affords 
Conclusions
The reaction of pentafluoropyridine with BoceThreOMe (11) in the presence of a base was not found to generate any elimination products. However, the reaction of mono-protected threonine (methyl ester, 12) under the same reaction conditions allowed the stereo-selective preparation of a novel dehydrobutyrine-containing amino acid (13) . The yield for the formation of dehydrobutyrine 13 could be increased to 65% by simple modification of the work up procedure. The elimination pathway was investigated and the reaction is proposed to proceed via an E1cb-type mechanism, which is enabled by the presence of an O-fluoropyridyl leaving group. Dehydrobutyrine 13 offers a unique opportunity for the dual tagging of peptides (i.e., reaction on the fluoropyridine ring and Michael addition) and potential applications in this area are currently under investigation.
Experimental

General
NMR spectra were collected using Bruker Avance 400 MHz, Varian VNMRS 600 MHz and a Varian VNMRS 700 MHz spectrometers. multiplicities; s¼singlet, d¼doublet, dd¼doublet of doublets, m¼multiplet, t¼triplet, q¼quartet, qd¼quartet of doublets, p¼pentet, br s¼broad singlet. Chemical shifts are reported in parts per million (ppm) and are referenced to residual solvent peaks; CHCl 3 ( 1 H 7.26 ppm, 13 C 77.2 ppm) and DMSO ( 1 H 2.50 ppm, 13 C 39.5 ppm). J couplings are measured in hertz (Hz). Reactions were monitored by TLC using Merck precoated silica gel plates. Column chromatography was performed using silica gel with the solvent system indicated. All reported yields refer to the isolated yield and the product purity was estimated to be >95% by 1 H NMR.
IR spectra were recorded on a Perkin Elmer Spectrum RX1 fitted with an ATR attachment. IR absorptions reported are in cm
À1
. L-alloThreonine methyl ester hydrochloride was purchased from Bachem. All other chemicals were purchased from Sigma Aldrich. Mass spectra were collected on a Waters TQD mass spectrometer and accurate mass spectra were collected on a Waters LCT Premier XE mass spectrometer. Optical rotations were measured with a Jasco P-1020 polarimeter using CHCl 3 as solvent. ortho (o) and meta (m) are with respect to nitrogen in the ring.
General procedures
4.2.1. General procedure A: reaction of threonine derivative with pentafluoropyridine (PFP) in the presence of potassium carbonate. PFP (2 equiv) was added to a stirred suspension of amino acid starting material (200 mg, 1 equiv), potassium carbonate (3 equiv) and acetonitrile (8 mL) and left to stir at room temperature for 18 h and purified as indicated below.
4.2.1.1. Purification procedure A: filtration work up method. The reaction mixture was filtered and washed with acetonitrile (2Â10 mL). The filtrate was concentrated in vacuo to afford the crude product, which was purified by column chromatography on silica (20% ethyl acetate, 80% hexane).
4.2.1.2. Purification procedure B: extraction work up method.-Acetonitrile was evaporated from the reaction mixture under reduced pressure and the resulting crude mixture was partitioned between chloroform (15 mL) and water (15 mL). The aqueous layer was washed twice with chloroform (2Â10 mL) and the combined organic extracts were dried (MgSO 4 ). Volatiles were removed in vacuo to give a crude mixture, which was purified by column chromatography on silica.
4.3. N-(2,3,5,6-Tetrafluoropyridine)-dehydrobutyrine methyl ester (13) General reaction procedure A was followed using threonine methyl ester hydrochloride (12) (200 mg, 1.24 mmol) , PFP (0.27 mL, 2.48 mmol) and potassium carbonate (513 mg, 3.71 mmol). Purification procedure B without the column chromatography step to give 13 as a white crystalline solid (200 mg, 65%).
Note: According to general procedure A and purification procedure A; employing L-allo-threonine methyl ester (0.20 g, 1.24 mmol), the same product (13) was also obtained as a white crystalline solid (7 mg, 2%). Mp 107e109 C; n max /cm PFP (0.27 mL, 2.48 mmol) was added to a stirred suspension of Lthreonine methyl ester hydrochloride (12) (200 mg, 1.24 mmol), DIPEA (0.65 mL, 3.72 mmol) and acetonitrile (8 mL) and left to stir at room temperature overnight. Acetonitrile was removed in vacuo and the resulting yellow oil was purified by column chromatography on silica (25% ethyl acetate, 75% hexane) to give 14 as a colourless oil (100 mg, 28%). n max /cm PFP (0.27 mL, 2.48 mmol) was added to a stirred suspension of Lthreonine methyl ester hydrochloride (12) (200 mg, 1.24 mmol) and potassium carbonate (513 mg, 3.71 mmol) in acetonitrile (8 mL) and stirred at room temperature overnight. Additional PFP (0.27 mL, 2.48 mmol) was added to the reaction mixture and stirred for a further 18 h. A final portion of PFP (0.27 mL, 2.48 mmol) was added to the reaction mixture and left to stir for 18 h. General reaction procedure A was followed using L-allo-threonine methyl ester hydrochloride (16) (200 mg, 1.24 mmol), PFP (0.27 mL, 2.48 mmol) and potassium carbonate (513 mg, 3.71 mmol). Purification procedure A was followed to give 17 as a colourless oil (139 mg, 50% 
X-ray crystallography
The X-ray single crystal data have been collected at 120(1) K on Agilent Gemini S-Ultra (13) and Bruker SMART CCD 6000 (15) diffractometers equipped with Cryostream (Oxford Cryosystems) open-flow nitrogen cryostats. Both structures were solved by direct method and refined by full-matrix least squares on F 2 for all data using Olex2 12 and SHELXTL 13 software. All non-hydrogen atoms were refined anisotropically, hydrogen atoms in both structures were located at the difference Fourier maps and refined isotropically, except those at C(10) methyl group in the structure 15, which were refined in riding mode. Crystallographic data for the structure have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication CCDC-972263e972264. 
